The announcement that Open USD will be available natively on the Solana network from day one has once again put the spotlight on SOL’s price action. This new stablecoin, focused on institutional use, highlights the Solana ecosystem’s ongoing efforts to expand its roster of supported stablecoins.
Solana announced Open USD will launch natively, boosting its stablecoin market above $15 billion
Why is the Open USD move under watch?
Although the introduction of Open USD is unlikely to trigger an immediate spike in SOL’s price, it is being closely monitored as a key step toward growing Solana’s payment infrastructure and on-chain financial use cases. At the time of the news, SOL traded at $73.67, marking a 1.98% drop in the previous 24 hours.
Solana stands out among Layer 1 blockchain networks due to its high transaction speeds, relatively low fees, and an expanding range of applications across decentralized finance and payment systems. The growth of stablecoin offerings within the network is viewed as an important indicator of rising liquidity and user engagement.
Solana stated that Open USD would be available natively from launch, with no minting or redemption fees for participating businesses, no volume caps, and governance managed through a shared structure.
According to the announcement, Open USD will operate locally on Solana, with no fees for minting, no upper limit on transaction volume, and the bulk of reserve income returned to businesses leveraging the system. This model is designed to enhance Solana’s appeal for enterprise payments and usage.
Mini glossary: Open Interest refers to the total number of active contracts in futures and derivatives markets. An increase in this metric suggests growing market interest and position-taking, but is not a definitive indicator of trend direction on its own.
What are the key price levels?
On the daily chart, SOL has rebounded from the $63 lows seen in June, maintaining support above $71.40. However, the $80 level—viewed as the next major resistance—remains unbroken for now.
The On-Balance Volume (OBV), a volume-based indicator, is trending upwards, signaling renewed buying interest. Still, as OBV has yet to reach previous highs, a clear breakout above $80 may require further accumulation and confirmation from market participants.
The significance of a $15 billion stablecoin base
According to DefiLlama, the market capitalization of stablecoins on Solana has exceeded $15 billion. This substantial figure points to an expanding liquidity foundation and a more favorable environment for payments and decentralized finance transactions on the network.
CoinGlass data also show that open interest has rebounded to around $5.5 billion, an indication that trader and investor engagement is picking up after last month’s correction. Nevertheless, since open interest remains below the year’s earlier highs, full market participation has not yet returned to previous strength.
While SOL’s price continues to move cautiously, the recovery in open positions suggests that traders are waiting for a decisive breakout. If SOL sustains above $80, the $85–$90 range could once again come into play. However, losing the $71 support could raise the risk of retreating back to the $63 area.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The "Outlier" Investment Art in the New Era of Berky

Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India
Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge
The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales
Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.

